Traduction de «pas de sexe de patient fourni » (Français → Anglais) :

This report addresses important issues: the definition of healthcare remains with the Member States, costs are paid at the same levels as if care had been provided in the Member State, the question of healthcare for patients with rare diseases is addressed, regardless of whether they are covered by the patient’s Member State of origin, proposals on the introduction of the position of European ombudsman to examine patients’ complaints are a move in the right direction and, finally, it emphasises the need for an information campaign to ...[+++]advise patients of their rights.

The most important challenge for teleradiology is to ensure that it develops in a manner that benefits patient care and ensures overall patient safety, and does not in any way reduce the quality of radiology services provided to the citizen.

From a medical point of view, the proposal to administer medicines on a gender-specific basis is entirely misguided, since it is standard practice to adapt dosages to a patient’s body weight or age.

I should also like to point out the need to invest in health research with patients’ gender taken into account.

Records of the age and sex of patient, type of treatment, toxic effects and life span from commencement of treatment would be valuable information in allocating funds for HIV/AIDS support in developing countries.

In 2012, the project RARECARENET (Information Network on Rare Cancers)[46], which built upon some of previous activities of the Project RARECARE (Surveillance of Rare Cancers in Europe)[47] which provided estimations for incidence, survival, prevalence and mortality for all rare cancers. The project aims (i) to provide updated indicators of rare cancer burden, (ii) to collect and disseminate information on the health care pathways for rare cancers, (iii) to identify the criteria for centres of expertise for rare cancers, (iv) to produce and disseminate information on diagnosis and management of rare cancers, (v) to develop a clinical dat ...[+++]abase on very rare cancers, (vi) to provide new knowledge on these diseases and their clinical management, and (vii) to develop and disseminate information for patients including a list of patients’ associations dedicated to rare cancers. In 2013, the European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment (ExPO-r-NeT), to support the provision of healthcare to children and young people with cancer in a Member State other than the Member State of affiliation, when the expertise with certain cancer conditions is rare and case volume low, contributing to provide cross-border best care to rare childhood cancer populations.